acnemaven.com

Katie Couric skinpeel

Wed, 18 Jul 2007 17:28:57 +0000

Katie Couric uses the Silkpeel system. It's is microdermabrasion system involving a rejuvenating, 20-minute, simultaneous exfoliation and serum infusion, which is delivered using a diamond wand.

It eliminates the need for abrasive particles while allowing for a customized serum infusion to effectively treat not only fine wrinkles caused by dry skin, but also hyperpigmentation,and acne. Silkpeel rapidly removes uneven patches of skin, signs of sun damage, fine lines, and break outs. Additional benefits include reduction of puffiness and firmer muscle

Accutane raises Cholesterol And Triglycerid

acnemaven — Wed, 13 Sep 2006 09:51:10 +0000

A recent entry in the august issue of the Archives of Dermatology highlights a study carried out by research staff at the University of California, San Francisco. Their research showed that the risk of raised cholesterol and/or triglyceride levels in the blood was higher than previouslty espected.

Dr. Lee T. Zane, said "Having abnormal tests results does not necessarily signal a bad medical outcome. It's just lab tests, not heart attacks. Isotretinoin is undeniably the most effective medication we have for treating severe acne. It can truly be life-changing. We can't lose sight of the fact that isotretinoin is the most important revolution in medical dermatology in the last 30 years."

Accutane should not be taken by pregnant women as it has been linked to birth defects.

The team of researchers say that do not know if children who take Accutane will increase their chances of developing cardiovascular problems when they become adults.

AlphaRx Inc receives notice of allowance for patent application “Stabilization of Benzoyl Peroxide in Solution”

acnemaven — Tue, 12 Sep 2006 10:32:34 +0000

MARKHAM, Ontario, Jan. 25, 2006 (PRIMEZONE) — AlphaRx Inc. (OTCBB:ALRX), an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs, has received a Notice of Allowance from the United States Patent and Trademark Office for its patent application entitled “Vehicle For Topical Delivery of Anti-Inflammatory Compounds.” The platform is an integral part of the Company’s lead product Indaflex(tm), which is undergoing a Phase II clinical trial.

Michael Lee, President of AlphaRx Inc., stated, “We are extremely pleased about the allowance of this patent. This award helps protect our innovative drug delivery technology and further endorses our competitive position. We have 6 further patent applications pending and are hopeful that this is the first of many patents that will be receiving allowance.”

About Indaflex(tm)

Indaflex(tm) is AlphaRx’s topical NSAID (Non-Steroidal Anti-inflammatory Drug) formulation under clinical development for the symptomatic treatment of osteoarthritis. Arthritis is the most common chronic disease in North America and afflicts an estimated 10% of the world’s population. Indaflex’s active ingredient, Indomethacin, has a long-standing and proven clinical treatment record. With AlphaRx’s enhanced proprietary delivery system, the company believes its’ clinical effectiveness will be significantly enhanced compared to other topical preparations. Topical Indaflex(tm) delivery, the company hopes, may circumvent the significant GI side-effects commonly found with orally ingested NSAID’s.

About AlphaRx Inc.

AlphaRx is an emerging biopharmaceutical company utilizing proprietary drug delivery technology to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method. The Company’s product candidates address various pharmaceutical markets, including arthritis, tuberculosis, ocular infection and inflammation, cataracts, hospital acquired pneumonia and sepsis.

Forward Looking Statements:

This release contains forward-looking statements within the meaning and pursuant to the Safe Harbor provisions of the Securities Litigation Reform Act of 1995 and involve risks and uncertainties that may individually or mutually impact the matters herein described, including but not limited to product development and acceptance, manufacturing, competition, regulatory and/or other factors, which are outside the control of the Company.

This press release is available on the company’s official on-line investor relations site for investor commentary, feedback and questions.

Jellyfish injections for acne

Tue, 22 Aug 2006 09:46:44 +0000

Two inventors working for a US company called Nanocyte have applied for a patent on a drug delivery system based on the stinging cells of jellyfish.Â Jelly fish posses stinging cells called cnidocysts which when triggered, shoot a hollow thread at high speed through which poison is pumped into the target.Â

The researchers have suggested a system based onÂ stinging cells whose poison has been removed and which are then primed with the drug to be injected.Â These cellsÂ canÂ then be applied to the patient on a skin patch.Â Drug delivery would be triggered byÂ a combination of pressure andÂ low voltageÂ electric pulses.Â Â Cells triggered in this manner will behave in the standard way, shooting outÂ threads whichÂ penetrate the patients skin and deliver the medication painlessly.Â Removal of the tubesÂ is achived by simply removing the patch.

The researches believe that this technology offers promise for the treatment of a range of skin complaints including acne.

Linsay Lohan promotes anti acne treatment Proactiv Solution

Wed, 12 Jul 2006 09:59:33 +0000

Guthy-Renker unveiled Linsay Lohan as one of the new faces of Proactiv Solution.Â
Their brand will launch its 10th national US television program featuring Lohan in July 2006.Â Lohan will share her experiences fighting acne and using Proactiv Solution.Â

Lohan has used the product with great success for many years and felt compelled to share her experience with the audience.Â She was quoted as saying, “My skin, thanks to Proactiv, is clear all the time,” “Proactiv heals acne, but the best thing is that it’s super gentle, so it works every day like skin care. That’s how I use it, and it works.” Â Â Â
Â

Proactiv Solution are understandably very upbeat about Lohan’s association with the product and the senior vice president Karen Barner Â said, “Celebrities have access to nearly every skin care product, and they choose Proactiv because it works.Â We’re thrilled that Lindsay uses Proactiv Solution and is happy to speak out in support of the brand. As Proactiv celebrates its 10th program, the life-changing product not only remains more popular and relevant than ever, but the response to the product continues to be remarkable.”

Proactiv Solution is used by more than 10 million people and Â is the result of five years of research by two leading Stanford-trained dermatologists, Dr. Katie Rodan and Dr. Kathy Fields. Â

Proactiv Solution was launched in 1995. Proactiv Solution has a range of products which include concealers, sunscreens and body washes to compliment a core three-step system.

Guthy-Renker is one of the worlds largest direct response television marketing companies.Â

Antibiotic free preparation shows promise in fighting acne

acnemaven — Sun, 03 Jul 2005 09:29:51 +0000

A Florida dermatologist names Dr Goodless, has successfully produced a tablet based on a combination of seven vitamins and one herb that

This treatmentÂ could provide another valuable option in the light of the rise of antibiotic resistant bacterial infections such as MRSA.

All of the vitamins concerned had already been proven by clinical trials to reduce the symptoms of acne.

This treatment was result of Dr Goodless’s study of existing medical literature and observations that traditional Chinese and Japanese herbal preparations.Â These preparations contain a substance called berberine which is has been found to inhibit the growth of proprionobacterium the bacteria known to cause acne.Â Â This the combination of the aforementioned vitamins and berberine rich herbs show great promise as a anti acne formulation.